Backs FY26 revenue view $16.4B-$16.8B, consensus $16.5B. Cuts FY26 adjusted EBITDA view to $4.23B-$4.53B from $5B-$5.3B. Guidance updated exclusively for Emalex transaction.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TEVA: